Indeed, in prostate carcinoma cells, Runx2 is expressed and correlates with metastatic potential [56], while in breast carcinoma cells Runx2 increases with respect to normal mammary tissue and regulates the expression of osteoblast-related genes [55]. Here, RUNX2 is linked to prostate carcinoma.